IBDEI0Z5 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35386,1,3,0)
 ;;=3^Bipolar & Related Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,35386,1,4,0)
 ;;=4^F31.89
 ;;^UTILITY(U,$J,358.3,35386,2)
 ;;=^5003520
 ;;^UTILITY(U,$J,358.3,35387,0)
 ;;=F31.9^^130^1698^5
 ;;^UTILITY(U,$J,358.3,35387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35387,1,3,0)
 ;;=3^Bipolar & Related Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,35387,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,35387,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,35388,0)
 ;;=A81.00^^130^1699^8
 ;;^UTILITY(U,$J,358.3,35388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35388,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35388,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,35388,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,35389,0)
 ;;=A81.09^^130^1699^7
 ;;^UTILITY(U,$J,358.3,35389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35389,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,35389,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,35389,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,35390,0)
 ;;=A81.2^^130^1699^72
 ;;^UTILITY(U,$J,358.3,35390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35390,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,35390,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,35390,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,35391,0)
 ;;=F01.50^^130^1699^46
 ;;^UTILITY(U,$J,358.3,35391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35391,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,35391,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,35391,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,35392,0)
 ;;=F01.51^^130^1699^47
 ;;^UTILITY(U,$J,358.3,35392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35392,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,35392,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,35392,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,35393,0)
 ;;=F02.80^^130^1699^34
 ;;^UTILITY(U,$J,358.3,35393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35393,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,35393,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,35393,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,35394,0)
 ;;=F02.81^^130^1699^35
 ;;^UTILITY(U,$J,358.3,35394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35394,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,35394,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,35394,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,35395,0)
 ;;=G30.9^^130^1699^4
 ;;^UTILITY(U,$J,358.3,35395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35395,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35395,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,35395,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,35396,0)
 ;;=G31.01^^130^1699^70
 ;;^UTILITY(U,$J,358.3,35396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35396,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,35396,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,35396,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,35397,0)
 ;;=G94.^^130^1699^6
 ;;^UTILITY(U,$J,358.3,35397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35397,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,35397,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,35397,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,35398,0)
 ;;=G31.83^^130^1699^18
 ;;^UTILITY(U,$J,358.3,35398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35398,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,35398,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,35398,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,35399,0)
 ;;=G31.89^^130^1699^11
 ;;^UTILITY(U,$J,358.3,35399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35399,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,35399,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,35399,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,35400,0)
 ;;=G31.9^^130^1699^12
 ;;^UTILITY(U,$J,358.3,35400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35400,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,35400,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,35400,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,35401,0)
 ;;=G23.8^^130^1699^10
 ;;^UTILITY(U,$J,358.3,35401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35401,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,35401,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,35401,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,35402,0)
 ;;=G30.0^^130^1699^2
 ;;^UTILITY(U,$J,358.3,35402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35402,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,35402,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,35402,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,35403,0)
 ;;=G30.1^^130^1699^3
 ;;^UTILITY(U,$J,358.3,35403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35403,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,35403,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,35403,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,35404,0)
 ;;=B20.^^130^1699^21
 ;;^UTILITY(U,$J,358.3,35404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35404,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,35404,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,35404,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,35405,0)
 ;;=G10.^^130^1699^22
 ;;^UTILITY(U,$J,358.3,35405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35405,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,35405,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,35405,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,35406,0)
 ;;=G30.8^^130^1699^1
 ;;^UTILITY(U,$J,358.3,35406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35406,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,35406,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,35406,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,35407,0)
 ;;=A81.89^^130^1699^5
 ;;^UTILITY(U,$J,358.3,35407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35407,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,35407,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,35407,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,35408,0)
 ;;=G20.^^130^1699^69
 ;;^UTILITY(U,$J,358.3,35408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35408,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,35408,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,35408,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,35409,0)
 ;;=G23.1^^130^1699^73
 ;;^UTILITY(U,$J,358.3,35409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35409,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,35409,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,35409,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,35410,0)
 ;;=F03.91^^130^1699^17
 ;;^UTILITY(U,$J,358.3,35410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35410,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,35410,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,35410,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,35411,0)
 ;;=F03.90^^130^1699^19
 ;;^UTILITY(U,$J,358.3,35411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35411,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,35411,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,35411,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,35412,0)
 ;;=F02.81^^130^1699^40
 ;;^UTILITY(U,$J,358.3,35412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35412,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,35412,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,35412,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,35413,0)
 ;;=F02.80^^130^1699^41
 ;;^UTILITY(U,$J,358.3,35413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35413,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
